GLYCERYL MONOSTEARATE
Molecular Excipient
Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
---|---|---|---|---|---|---|
359.0 | 5.1 | 2 | 4 | 67.0 | 19 | 0.95 |
- CAS
- 31566311
- UNII
- 230OU9XXE4
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 36 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Dosages
Route | Formulation | Per Unit Dose |
---|---|---|
Auricular (Otic) | Suspension | 0.5% |
Dental | Paste | 64MG |
Ophthalmic | Suspension | 0.5% |
Oral | Capsule, Delayed Action | 0.2MG |
Oral | Capsule, Delayed Action | 1.9MG |
Oral | Capsule, Hard Gelatin | 13.75MG |
Oral | Capsule, Sustained Action | 27MG |
Oral | Granule, For Oral Suspension | 1.9MG |
Oral | Pellet | 1.9MG |
Oral | Tablet | 0.3MG |
Oral | Tablet | 5.6MG |
Oral | Tablet (Immed./comp. Release), Uncoated, Chewable | 0.25MG |
Oral | Tablet, Delayed Action | 1.4MG |
Oral | Tablet, Delayed Action, Enteric Coated | 0.01MG |
Oral | Tablet, Extended Release | 17MG |
Oral | Tablet, Extended Release | 0.52MG |
Oral | Tablet, Orally Disintegrating, Delayed Release | 7.5MG |
Oral | Tablet, Sustained Action | 34MG |
Oral | Tablet, Sustained Action | 154MG |
Oral | Tablet, Sustained Action, Film Coated | 264.3MG |
Rectal | Suppository | 35MG |
Rectal | Suppository | 32.3MG |
Sublingual | Tablet | 1.23MG |
Topical | Cream | 2.5%W/W |
Topical | Cream, Emulsion, Sustained Release | 8.5%W/W |
Topical | Cream, Emulsion, Sustained Release | 5%W/W |
Topical | Emulsion, Aerosol Foam | |
Topical | Emulsion, Cream | 10%W/W |
Topical | Emulsion, Cream | 20% |
Topical | Lotion | 3% |
Topical | Lotion | 0.5%W/W |
Topical | Lotion | 9% |
Topical | Ointment | 5% |
Topical | Suppository | 5% |
Topical | Suspension | 1.25% |
Vaginal | Cream, Emulsion, Sustained Release | 1% |
Vaginal | Emulsion, Cream | 17% |